ASSESSMENT OF CHANGE IN QUALITY OF LIFE (QOL), CARCINOID SYNDROME (CS) SYMPTOMS, AND HEALTH CARE RESOURCE UTILIZATION (HRU) IN CS PATIENTS TREATED WITH SOMATOSTATIN ANALOGS (SSA) -- RESULTS FROM LONGITUDINAL PATIENT SURVEYS

被引：0
|
作者：
Huynh, L. [1 ]
Bhak, R. [1 ]
Narkhede, S. [1 ]
Beaumont, J. L. [2 ]
Halperin, D. M. [3 ]
Cai, B. [4 ]
Duh, M. S. [1 ]
Neary, M. P. [4 ]
Chang, R. [1 ]
Cella, D. [5 ]
机构：
[1] Anal Grp Inc, Boston, MA USA
[2] Terasaki Res Inst, Los Angeles, CA USA
[3] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[4] Novartis Pharmaceut, E Hanover, NJ USA
[5] Northwestern Univ, Chicago, IL 60611 USA
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.320
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN174
引用
收藏
页码：S38 / S39
页数：2
相关论文
共 7 条
  • [1] Improvement of carcinoid syndrome (CS) symptoms and quality of life (QoL) in CS patients treated with somatostatin analogs (SSAs): Results from longitudinal patient surveys.
    Halperin, Daniel M.
    Huynh, Lynn
    Beaumont, Jennifer L.
    Cai, Beilei
    Bhak, Rachel
    Narkhede, Sahil
    Duh, Mei Sheng
    Neary, Maureen
    Cella, David
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (04)
  • [2] Improvement of Carcinoid Syndrome (CS) Symptoms and Quality of Life (QoL) in CS Patients TreatedWith Somatostatin Analogs (SSAs)
    Halperin, Daniel M.
    Huynh, Lynn
    Beaumont, Jennifer L.
    Cai, Beilei
    Bhak, Rachel
    Narkhede, Sahil
    Duh, Mei S.
    Neary, Maureen P.
    Cella, David
    [J]. PANCREAS, 2019, 48 (03) : 436 - 436
  • [3] Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome
    Daniel M. Halperin
    Lynn Huynh
    Jennifer L. Beaumont
    Beilei Cai
    Rachel H. Bhak
    Sahil Narkhede
    Todor Totev
    Mei S. Duh
    Maureen P. Neary
    David Cella
    [J]. BMC Cancer, 19
  • [4] Assessment of change in quality of life, carcinoid syndrome symptoms and healthcare resource utilization in patients with carcinoid syndrome
    Halperin, Daniel M.
    Huynh, Lynn
    Beaumont, Jennifer L.
    Cai, Beilei
    Bhak, Rachel H.
    Narkhede, Sahil
    Totev, Todor
    Duh, Mei S.
    Neary, Maureen P.
    Cella, David
    [J]. BMC CANCER, 2019, 19 (1)
  • [5] Treatment Satisfaction, Symptom Control and Quality of Life (QoL) with Lanreotide Autogel (LAN) in NET Patients with Carcinoid Syndrome (CS): Results from the SYMNET Study
    Ruszniewski, P.
    Caplin, M.
    Valle, J.
    Lombard-Bohas, C.
    Poston, G.
    Perros, P.
    Holubec, L.
    Delle Fave, G.
    Smith, D.
    Niccoli, P.
    Maisonobe, P.
    Atlan, P.
    [J]. NEUROENDOCRINOLOGY, 2015, 102 (1-2) : 126 - 126
  • [6] Treatment Satisfaction, Symptom Control, and Quality of Life (QoL) With Lanreotide Autogel/Depot (LAN) in Neuroendocrine Tumor (NET) Patients With Carcinoid Syndrome (CS): Results From the SymNET Study
    Ruszniewski, Philippe
    Caplin, Martyn E.
    Valle, Juan W.
    Lombard-Bohas, Catherine
    Poston, Graeme
    Perros, Petros
    Holubec, Lubos
    Delle Fave, Gianfranco
    Smith, Denis
    Niccoli, Patricia
    Maisonobe, Pascal
    Gomez-Panzani, Edda
    [J]. PANCREAS, 2015, 44 (02) : 357 - 358
  • [7] Health-related quality of life, work productivity, and health care resource utilization of subjects with irritable bowel syndrome:: Baseline results from LOGIC (longitudinal outcomes study of gastrointestinal symptoms in Canada), a naturalistic study
    Pare, Pierre
    Gray, James
    Lam, Sy
    Balshaw, Robert
    Khorasheh, Shideh
    Barbeau, Martin
    Kelly, Suzanne
    McBurney, Christopher R.
    [J]. CLINICAL THERAPEUTICS, 2006, 28 (10) : 1726 - 1735
1